Investigation by the Department of Justice (DOJ) over UnitedHealth's Medicare billing procedures
The U.S. Department of Justice (DOJ) is currently investigating UnitedHealth Group, one of the nation's largest health insurers, over its Medicare Advantage billing practices. The investigation, which is both criminal and civil in nature, focuses on the company's diagnosis coding that has resulted in increased federal payments under the Medicare Advantage program.
The investigations stem from concerns that UnitedHealth's handling of diagnoses may have maximized federal reimbursements improperly. The news of the investigation was first reported by The Wall Street Journal in February, and it has been ongoing since then. In May, the Journal reported about the ongoing criminal investigation into UnitedHealth Group, and in July, it was reported that the DOJ had interviewed several doctors about the company's practices.
UnitedHealth Group has proactively contacted the DOJ and is cooperating fully with the formal requests from the department. The company has expressed confidence in its billing practices, citing a long-standing record of compliance and independent audits by the Centers for Medicare & Medicaid Services (CMS) that verify its practices as among the most accurate in the industry.
The investigation comes at a challenging time for UnitedHealth, which reported $400 billion in revenue for 2024 and is also under DOJ antitrust review for its planned $3.3 billion acquisition of home-health firm Amedisys. UnitedHealth has reiterated its commitment to cooperating with authorities and responsibly managing taxpayer funds throughout the investigation.
The civil investigation is aimed at determining if UnitedHealth inflated diagnoses to trigger extra payments to its Medicare Advantage plans. The doctors who were questioned by the DOJ were asked about whether they felt pressured to submit claims for certain conditions that bolstered payments from the Medicare Advantage program to UnitedHealth Group.
This is the second time in 2021 that UnitedHealth's Medicare Advantage business has come under federal scrutiny. In February, the DOJ was reported to be conducting a civil investigation into UnitedHealth Group over inflated diagnoses. The Justice Department is conducting a criminal investigation into UnitedHealth Group over possible Medicare fraud.
As of now, no further specific details of alleged wrongdoing, case scope, or timeline have been publicly disclosed. UnitedHealth Group has not commented on the specific allegations beyond stating that it is cooperating with the DOJ's investigation.
- The ongoing investigation by the Department of Justice (DOJ) raises questions about UnitedHealth Group's practices in the health-and-wellness sector, specifically its handling of diagnoses and billing under the Medicare Advantage program.
- The company's business operations, including its trading in the markets and revenue generation, could potentially be affected if the DOJ's investigation uncovers improper practices related to Medicare Advantage billing.
- As a large player in the health insurance market, UnitedHealth's ongoing investigation adds to the growing discussions in the finance and business communities about the need for transparency and accountability in the industry.
- The science of diagnosis coding and its impact on federal payments serves as a reminder of the intricate intersection between the healthcare sector and the broader economy, particularly in terms of revenue and finance management.
%20over%20UnitedHealth's%20Medicare%20billing%20procedures){kind=link}